ACHE and Alzheimer disease: The theory behind the “cholinergic hypothesis” led to the development of not only several acetylcholinesterase inhibitors (AChEIs), but also many examples of dual- or multi-target compounds combining inhibitory effects in AChE with other AD-related targets (the so-called multi-target cholinesterase inhibitors) [65,66].